World's Largest Resource for Cardiovascular Perfusion
Thus, it is envisioned that this biomimetic erythrocyte membrane surface strategy will provide a promising way to mitigate inflammation and thrombosis caused by the use of blood-contacting catheters.
Aim of this study was to assess the prevalence, clinical meaning and modifications of mitral regurgitation (MR) in patients undergoing transcatheter aortic valve implantation (TAVI).
Bayer was glad to participate in today’s advisory committee meeting held by the Cardiovascular and Renal Drugs Division of the U.S. Food and Drug Administration (FDA). This session provided an open forum in which to discuss the complex scientific issues surrounding the risk/benefit profile of Trasylol® (aprotinin injection) in detail.